YU264072A - Process for preparing penicillins - Google Patents

Process for preparing penicillins

Info

Publication number
YU264072A
YU264072A YU02640/72A YU264072A YU264072A YU 264072 A YU264072 A YU 264072A YU 02640/72 A YU02640/72 A YU 02640/72A YU 264072 A YU264072 A YU 264072A YU 264072 A YU264072 A YU 264072A
Authority
YU
Yugoslavia
Prior art keywords
penicillins
preparing
preparing penicillins
Prior art date
Application number
YU02640/72A
Other languages
English (en)
Inventor
Koenig Hans-Bodo
Hans-Bodo Koenig
Schroeck Wilfried
Wilfried Schroeck
Metzger Karl-Georg
Karl-Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of YU264072A publication Critical patent/YU264072A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
YU02640/72A 1971-10-23 1972-10-23 Process for preparing penicillins YU264072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
YU264072A true YU264072A (en) 1982-06-18

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02640/72A YU264072A (en) 1971-10-23 1972-10-23 Process for preparing penicillins

Country Status (31)

Country Link
JP (2) JPS55391B2 (cs)
AR (1) AR195805A1 (cs)
AT (1) AT320152B (cs)
BE (1) BE790440A (cs)
BG (2) BG20813A3 (cs)
CA (1) CA1019323A (cs)
CH (1) CH579089A5 (cs)
CS (1) CS188883B2 (cs)
CY (1) CY947A (cs)
DD (1) DD106044B3 (cs)
DE (1) DE2152967C3 (cs)
DK (1) DK134992C (cs)
EG (1) EG10826A (cs)
ES (1) ES407851A1 (cs)
FI (1) FI56839C (cs)
FR (1) FR2157908B1 (cs)
GB (1) GB1392849A (cs)
HK (1) HK18578A (cs)
HU (1) HU167986B (cs)
IE (1) IE37123B1 (cs)
IL (1) IL40628A (cs)
KE (1) KE2824A (cs)
LU (1) LU66332A1 (cs)
NO (1) NO143909C (cs)
PH (1) PH9893A (cs)
PL (2) PL93574B1 (cs)
RO (2) RO60670A (cs)
SE (1) SE412236B (cs)
SU (1) SU527139A3 (cs)
YU (1) YU264072A (cs)
ZA (1) ZA727473B (cs)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
ES2409215T3 (es) 2007-09-14 2013-06-25 Janssen Pharmaceuticals, Inc. 4-fenil-1H-piridin-2-onas 1-3-disustituidas
EP2200985B1 (en) 2007-09-14 2011-07-13 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
WO2009062676A2 (en) 2007-11-14 2009-05-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
BRPI0918055A2 (pt) 2008-09-02 2015-12-01 Addex Pharmaceuticals Sa derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato.
ES2466341T3 (es) 2008-10-16 2014-06-10 Janssen Pharmaceuticals, Inc. Derivados de indol y benzomorfolina como moduladores de receptores de glutamato metabotrópicos
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
KR101753826B1 (ko) 2009-05-12 2017-07-04 얀센 파마슈티칼즈, 인코포레이티드 1,2,4―트리아졸로[4,3―a]피리딘 유도체 및 신경정신 질환의 치료 또는 예방을 위한 이들의 용도
SG176018A1 (en) 2009-05-12 2011-12-29 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010142241A1 (en) * 2009-06-10 2010-12-16 Techfields Biochem Co., Ltd. High penetration compositions or prodrugs of antimicrobials and antimicrobial-related compounds
WO2012062751A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PT3096790T (pt) 2014-01-21 2019-10-15 Janssen Pharmaceutica Nv Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso
SMT202100103T1 (it) 2014-01-21 2021-03-15 Janssen Pharmaceutica Nv Combinazione comprendente modulatori allosterici postivi del recettore glutammatergico metabotropico sottotipo 2 e loro utilizzo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
BE790440A (cs) 1973-04-24
DK134992C (da) 1977-07-18
PL93574B1 (cs) 1977-06-30
JPS4849910A (cs) 1973-07-14
FR2157908B1 (cs) 1976-03-19
DE2152967B2 (de) 1981-02-19
IE37123L (en) 1973-04-23
BG21609A3 (bg) 1976-07-20
DE2152967C3 (de) 1981-11-19
GB1392849A (en) 1975-04-30
FR2157908A1 (cs) 1973-06-08
PH9893A (en) 1976-06-08
IL40628A (en) 1976-08-31
HK18578A (en) 1978-04-14
ES407851A1 (es) 1975-10-01
AR195805A1 (es) 1973-11-09
CA1019323A (en) 1977-10-18
LU66332A1 (cs) 1973-01-23
IL40628A0 (en) 1972-12-29
SU527139A3 (ru) 1976-08-30
BG20813A3 (bg) 1975-12-20
AU4806472A (en) 1974-04-26
EG10826A (en) 1976-12-31
FI56839B (fi) 1979-12-31
HU167986B (cs) 1976-02-28
NO143909C (no) 1981-05-06
CH579089A5 (cs) 1976-08-31
CY947A (en) 1978-06-23
JPS57843B2 (cs) 1982-01-08
DD106044A5 (cs) 1974-05-20
PL89056B1 (cs) 1976-10-30
NO143909B (no) 1981-01-26
DK134992B (da) 1977-02-21
RO63066A (fr) 1978-06-15
AT320152B (de) 1975-01-27
ZA727473B (en) 1973-07-25
IE37123B1 (en) 1977-05-11
RO60670A (cs) 1976-10-15
KE2824A (en) 1978-04-07
SE412236B (sv) 1980-02-25
DE2152967A1 (de) 1973-05-03
JPS4849787A (cs) 1973-07-13
FI56839C (fi) 1980-04-10
JPS55391B2 (cs) 1980-01-08
DD106044B3 (de) 1990-07-18
CS188883B2 (en) 1979-03-30

Similar Documents

Publication Publication Date Title
YU264072A (en) Process for preparing penicillins
YU298072A (en) Process for preparing isothiocyanobenzazoles
ZA725556B (en) Process for preparing an iron-saccharide complex
YU263872A (en) Process for preparing novel penicillins
CS180608B2 (en) Process for preparing dialkoxyxanthogendisulfines
YU216872A (en) Process for preparing cinnamoyl-5-benzofuran derivatives
CS190399B2 (en) Process for preparing caphalexine
YU204172A (en) Process for preparing 4-aza-benzimidazoles
YU142879A (en) Process for obtaining thiazoline-azetidinone
YU35261B (en) Process for preparing tertramisole
JPS53127458A (en) Process for preparing alphaaisopropylidenee11 azethidineacetate
YU36295B (en) Process for obtaining novel hydroxy-pyrimidines
ZA724841B (en) Process for preparing cephalosporings
CS190382B2 (en) Process for preparing 3-alkylthiomethyl-7-acylamidocephalosporines
YU35036B (en) Process for preparing steroid-21-alcohols
CS190379B2 (en) Process for preparing penicilinamine
YU34999B (en) Process for preparing novel substituted n-methalyl-n-phenyl-amino-imidazolines
YU115972A (en) Process for preparing 4-hydroxy-benzodioxides
YU47272A (en) Improved process for preparing 1-dihydrocodeine
YU259972A (en) Process for producing penicillin
ZA722397B (en) Process for preparing 5-hydroxy-1-tetralone
GB1400875A (en) Process for preparing cyclicdicarboximidophosphonothioates
YU35599B (en) Process for obtaining delta-carboxyarylmethyl-1-delta-carboaryloxyarylmethyl penicillins
YU34618B (en) Process for preparing 1-allyl-2-amino-methyl-pyrrolidines
CS190384B2 (en) Process for preparing rennete